ArriVent BioPharma Inc. C...
(AVBP)
undefined
undefined%
At close: undefined
26.72
0.49%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 |
Net Income | -69.33M | -36.91M | -51.61M |
Depreciation & Amortization | - | - | - |
Stock-Based Compensation | 895.00K | 424.00K | 66.67K |
Other Working Capital | 11.22M | -9.95M | -4.23M |
Other Non-Cash Items | - | -2.38M | 42.67M |
Deferred Income Tax | - | - | - |
Change in Working Capital | 12.60M | -7.15M | -3.94M |
Operating Cash Flow | -55.84M | -43.63M | -12.59M |
Capital Expenditures | - | - | - |
Acquisitions | - | - | - |
Purchase of Investments | -25.00M | - | - |
Sales Maturities Of Investments | 25.00M | - | - |
Other Investing Acitivies | - | - | -40.00M |
Investing Cash Flow | - | - | -40.00M |
Debt Repayment | - | - | - |
Common Stock Repurchased | - | - | - |
Dividend Paid | - | - | - |
Other Financial Acitivies | 42.86M | 169.72M | 119.82M |
Financial Cash Flow | 42.86M | 169.72M | 89.87M |
Net Cash Flow | -12.98M | 126.09M | 37.28M |
Free Cash Flow | -55.84M | -43.63M | -12.59M |